EUVIMEDEUVIMED entdecken
Crossref

Zero-fluoroscopy approach to left atrial appendage closure using intracardiac echo guidance

Michael H Hoskins, Michael Bestawros, Sandeep Nair, Yaw Adjei-Poku, Benjamin Remo, Sean Mazer

Heart Rhythm · 2026-10

DOI: 10.1016/j.hrthm.2026.10.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2026-10. Verfasst von Michael H Hoskins und 5 weiteren Autor:innen. Beteiligte Einrichtung: New Mexico Heart Institute, Lovelace Heart Hospital of New Mexico, Albuquerque, New Mexico. Electronic address: michael.hoskins@lovelace.com. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Left atrial appendage closure (LAAC) with the Watchman device is typically performed with the use of transesophageal echocardiography and fluoroscopy. LAAC guided by intracardiac echocardiography (ICE) without the use of fluoroscopy has not been previously described. OBJECTIVE: In this series, we describe the safety and feasibility of Watchman implantation using only ICE imaging and without the use of fluoroscopy. METHODS: 214 patients undergoing LAAC with the Watchman FLX or Watchman FLX Pro device and using a planned fluoroscopy-free approach were studied. ICE was used for echocardiographic imaging in all cases. Transesophageal echocardiography was not used in any cases. Fluoroscopy was used as a bailout approach when it was felt to be clinically necessary by the operator. Periprocedural, 45-day, and 1-year efficacy and safety outcomes were assessed. RESULTS: In 203 of 214 patients (94.8%), LAAC was completed without the use of fluoroscopy. Bailout fluoroscopy was required in 11 of 214 patients (5.1%). Successful device implantation was completed in 212 of 214 patients (99.1%). The rate of any peridevice leak at 45 days postprocedure was 11.6%. Procedural complications were limited to 1 pericardial effusion and 1 case of ventricular tachycardia. CONCLUSION: LAAC with the Watchman device using ICE imaging and without the use of fluoroscopy appears to be safe and effective. The rates of procedural success, complications, and peridevice leaks on 45-day follow-up were consistent with those seen in pivotal clinical trials. Further studies are needed to assess the broader applicability of this technique.

Schlagwörter

Stichwörter der Autor:innen

Atrial fibrillationIntracardiac echocardiographyLeft atrial appendage closureWatchman™

Autor:innen und Institutionen

  • New Mexico Heart Institute, Lovelace Heart Hospital of New Mexico, Albuquerque, New Mexico. Electronic address: michael.hoskins@lovelace.com.
  • New Mexico Heart Institute, Lovelace Heart Hospital of New Mexico, Albuquerque, New Mexico.

Zitieren

APA

Hoskins, M. H., Bestawros, M., Nair, S., Adjei-Poku, Y., Remo, B., & Mazer, S. (2026). Zero-fluoroscopy approach to left atrial appendage closure using intracardiac echo guidance. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2026.10.032

Vancouver

Hoskins MH, Bestawros M, Nair S, Adjei-Poku Y, Remo B, Mazer S. Zero-fluoroscopy approach to left atrial appendage closure using intracardiac echo guidance. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2026.10.032

BibTeX
@article{Hoskins2026,
  author = {Hoskins, Michael H and Bestawros, Michael and Nair, Sandeep and Adjei-Poku, Yaw and Remo, Benjamin and Mazer, Sean},
  title = {Zero-fluoroscopy approach to left atrial appendage closure using intracardiac echo guidance},
  journal = {Heart Rhythm},
  year = {2026},
  doi = {10.1016/j.hrthm.2026.10.032}
}
Kostenlos starten →